Cargando…
Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma
BACKGROUND: The heterogeneity of hepatocellular carcinoma (HCC) leads to the unsatisfying predictive performance of current staging systems. HCC patients with pathological tumor micronecrosis have an immunosuppressive microenvironment. We aimed to develop novel prognostic models by integrating micro...
Autores principales: | Sun, Xuqi, Wang, Yangyang, Ge, Hongbin, Chen, Cao, Han, Xu, Sun, Ke, Wang, Meng, Wei, Xiaobao, Ye, Mao, Zhang, Qi, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386864/ https://www.ncbi.nlm.nih.gov/pubmed/37521028 http://dx.doi.org/10.2147/JHC.S423687 |
Ejemplares similares
-
Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation
por: Wang, Yangyang, et al.
Publicado: (2023) -
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications
por: Sun, Xuqi, et al.
Publicado: (2022) -
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
por: Lin, Wen-Ping, et al.
Publicado: (2021) -
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
por: Sun, Xuqi, et al.
Publicado: (2021) -
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
por: Sun, Xuqi, et al.
Publicado: (2020)